Organometallic 99mTc-aquaion labels peptide to an unprecedented high specific activity

Journal of Nuclear Medicine

Volumn 40, Issue 11, 1999, Pages 1913-1917

  Egli, André ^a   Alberto, Roger ^b   Tannahill, Lesley ^b   Schibli, Roger ^b   Abram, Ulrich ^b   Schaffland, Andreas ^b   Waibel, Robert ^b   Tourwé, Dirk ^b   Jeannin, Lauren ^b   Iterbeke, Koen ^b   Schubiger, P August ^b  

^a ETH Zurich   (Switzerland)

^b NONE

Author keywords

99mTc; Histidine; Neurotensin; Peptides

Indexed keywords

AQUAION TECHNETIUM TC 99M; HISTIDINE; NEUROTENSIN DERIVATIVE; RADIOISOTOPE; TECHNETIUM 99M; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; NEUROTENSIN; PEPTIDE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM;

ARTICLE; BINDING AFFINITY; DRUG DISTRIBUTION; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; LIGAND BINDING; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; THERMODYNAMICS; ANIMAL; BAGG ALBINO MOUSE; HUMAN; TISSUE DISTRIBUTION;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HISTIDINE; HUMANS; ISOTOPE LABELING; MICE; MICE, INBRED BALB C; NEUROTENSIN; PEPTIDES; RADIOPHARMACEUTICALS; TECHNETIUM; TISSUE DISTRIBUTION;

EID: 0032589705     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Muto P, Lastoria S, Varrella P, et al. Detecling deep venous thrombosis with technetium-99m-labeled synthetic peptide P280 J Nucl Med. 1995;36:1384-1391.
2. Reubi JC. Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging. J Nucl Med. 1995;36:1825-1835.
3. Fischman AJ, Babich JW, Strauss HW. A ticket to ride: peptide radiopharmaceuticals. JNucl Med. 1993;34:2253-2263.
4. McAfee JG, Neumann RD. Radiolabeled peptides and other ligands for receptors overexpressed in tumor cells for imaging neoplasms. Nucl Med Biol. 1996;23:673-676.
5. Breeman WAP, Bakker WH, De Jong M, et al. Studies on radiolabeled somatostatin analogues in rats and in patients. Q J Nucl Med. 1996;40:209-220.
6. 123I-labeled vasoactive intestinal peptide (VIP) for the localization of intestinal adenocarcinomas and endocrine tumors. N Engl J Med. 1994;331:1116-1121.
7. 99mTc. Q J Nucl Med. 1996;40:221-233.
8. 99mTc labeling of highly potent small peptides. Bioconjugate Chem. 1997;8:621-636.
9. Abrams MJ, Davison A, Jones AG, Costello CE, Pang H. Synthesis and characterization of hexakis(alkyl isocyanide) and hexakis(aryl isocyanide) complexes of technetium(I). Inorg Chem. 1983;22:2798-2800.
10. 3]. J Organomet Chem. 1995;492:217-224.
11. 6] by alkaline titration. J Chem Soc Dalton Trans. 1994;2815-2820.
12. Egli A, Hegetschweiler K, Alberto R, et al. Hydrolysis of the organometallic aqua ion fac-triaquatricarbonylrhemum(I): mechanism, pKa, and formation constants of the polynuclear hydrolysis products. Organometallics. 1997;16:1833-1840.
13. 6]. Polyhedron. 1996;15:1079-1089.
14. 3" (M = Tc, Re) moiety for the labelling of biomolecules. Radiochim Acta. 1997;79:99-103.
15. + in aqueous solution and its reaction with a bifunctional ligand. J Am Chem Soc. 1998;120:7987-7988.
16. Vincent J-P. Neurotensin receptors: binding properties, transduction pathways, and structure. Cell Molec Neurobiol. 1995;15:501-512.
17. Qin Y, Ert T, Cai R-Z, Halmos G, Schally AV. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro. Cancer Res. 1994;54:1035-1041.